CARCINOMA, BRONCHOGENIC
Clinical trials for CARCINOMA, BRONCHOGENIC explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, BRONCHOGENIC trials appear
Sign up with your email to follow new studies for CARCINOMA, BRONCHOGENIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for common lung cancer mutation
Disease control OngoingThis study looks at how well the drug osimertinib combined with chemotherapy works as the first treatment for people with advanced EGFR-mutant non-small cell lung cancer. It involves 532 adults with stage IIIB, IIIC, or IV disease who cannot have surgery or radiation. Researchers…
Matched conditions: CARCINOMA, BRONCHOGENIC
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can doctor training boost lung cancer care in smaller cities?
Knowledge-focused OngoingThis study looks at whether educating doctors in small and mid-sized city hospitals can improve how they test and treat patients with advanced non-small cell lung cancer. About 1000 patients will be observed to see if more patients get the right molecular tests and targeted treat…
Matched conditions: CARCINOMA, BRONCHOGENIC
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC